Lack of baseline dissolution data makes evaluating risk of bioavailability enhancements tricky, researcher says
Bioavailability enhancements continue to be one of the most active development tangents in the dietary supplement ingredient industry. But even as these approaches gain market traction, basic information about the toxicological profiles of many of these...